Announcement on the Completion of the Board of Directors Election and Appointment of Senior Management and Other Personnel

Securities Code: 300347 Securities Abbreviation: Tigermed Announcement Code: (2026)033

Hangzhou Tigermed Technology Co., Ltd.

Announcement on the Completion of the Board of Directors Election and Appointment of Senior Management and Other Personnel

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement and bear joint and several liability for any false or misleading statements or material omissions.

Hangzhou Tigermed Technology Co., Ltd. (hereinafter referred to as the "Company") held its 2025 Annual General Meeting of Shareholders on June 2, 2026, which approved the relevant proposals for the election of the Board of Directors. The sixth Board of Directors was elected, comprising 3 executive directors and 3 independent non-executive directors. Together with Mr. Wu Hao, the employee representative director elected by the Company's Employees' Representative Meeting, the sixth Board of Directors was formed. To ensure the smooth operation of the Board of Directors, the Company held the First Meeting of the Sixth Board of Directors on the same day, combining in-person and teleconference methods. The meeting elected members of the specialized committees of the sixth Board of Directors and the Chairman, and appointed new senior management personnel and the Secretary of the Board. The relevant information is hereby announced as follows:

I. Composition of the Sixth Board of Directors

(I) Board Members

The sixth Board of Directors of the Company consists of 7 directors, including 3 executive directors, 3 independent non-executive directors, and 1 employee representative director. The specific members are as follows:

1. Executive Directors: Mr. Ye Xiaoping (Chairman), Ms. Cao Chunxian, Mr. Wen Zengyu
2. Independent Non-Executive Directors: Ms. Liu Yuwen, Mr. Yuan Huagang, Mr. Xiao Yaohui
3. Employee Representative Director: Mr. Wu Hao

The term of the sixth Board of Directors of the Company shall be three years from the date of approval by the 2025 Annual General Meeting of Shareholders.

All members of the sixth Board of Directors possess the qualifications to serve as directors of a listed company and are capable of fulfilling the requirements of their respective positions. The qualifications of the 3 independent non-executive directors were reviewed and approved by the Shenzhen Stock Exchange before the 2025 Annual General Meeting of Shareholders. The number of directors concurrently serving as senior management personnel and employee representative directors does not exceed one-half of the total number of directors, and the number of independent directors accounts for no less than one-third of the total number of directors.

(II) Members of the Board's Specialized Committees

1. Board Audit Committee Members: Mr. Xiao Yaohui, Mr. Yuan Huagang, Ms. Liu Yuwen; Mr. Xiao Yaohui serves as the convenor (Chairman).
2. Board Remuneration and Nomination Committee Members: Mr. Yuan Huagang, Mr. Xiao Yaohui, Ms. Cao Chunxian; Mr. Yuan Huagang serves as the convenor (Chairman).
3. Board Strategy Committee Members: Mr. Ye Xiaoping, Mr. Wu Hao, Mr. Yuan Huagang; Mr. Ye Xiaoping serves as the convenor (Chairman).
4. Board Nomination Committee Members: Ms. Liu Yuwen, Mr. Wen Zengyu, Mr. Xiao Yaohui; Ms. Liu Yuwen serves as the convenor (Chairman).

Among these, the Audit Committee, Nomination Committee, and Remuneration and Nomination Committee have a majority of independent directors and the convenor is an independent director. Mr. Xiao Yaohui, the convenor of the Audit Committee, is a professional in accounting. All members of the Audit Committee are directors who do not hold senior management positions in the Company, which complies with relevant regulations and the Articles of Association. The term of office for members of the specialized committees of the sixth Board of Directors shall be from the date of approval by the Board of Directors until the expiration of the term of the sixth Board of Directors. If a member ceases to hold the position of director during this period, they shall automatically forfeit their qualification as a member of the specialized committee, and the successor director shall automatically assume the corresponding specialized committee member position.